DrugsControl Media Services

News Detail

Give 'Fair Chance' Before Publicly Declaring names, Pharma Lobby to DCGI (04-05-2023)

New Delhi, 4 May 2023: The top drug makers in India have appealed to the Drug Controller General of India (DCGI), the country's apex drug regulator, for a "fair chance" before declaring the names and list of unusual quality drugs publicly.

Highlighting a similar concer......
View Details

Source : News 18
Drug Controller General of India (DCGI) Sudarshan Jain secretary general of IPA DCGI Rajeev Singh Raghuvanshi CDSCO reputation of the industry The alerts Not-of-standard quality (NSQ) drugs

Related News